Navigation Links
Ralph Alvarez Elected to Lilly Board of Directors
Date:2/18/2009

INDIANAPOLIS, Feb. 18 /PRNewswire-FirstCall/ -- The Board of Directors of Eli Lilly and Company (NYSE: LLY) has elected Ralph Alvarez as a new member, effective April 1, 2009. Alvarez, 53, currently serves as president and chief operating officer of McDonald's Corporation and is also a member of McDonald's board of directors. As a member of Lilly's board, Alvarez will serve on both the board's finance committee and public policy and compliance committee. He will serve under interim election and will stand for election by Lilly shareholders at the company's annual meeting in 2010.

"I am very pleased to welcome Ralph Alvarez to the Lilly board," commented John Lechleiter, Ph.D., Lilly chairman and chief executive officer. "Ralph has demonstrated strong leadership at McDonald's while overseeing a diverse, global organization. With over 30 years of exceptional service in the food service retailer industry, Ralph truly understands and appreciates the value of building a successful, global customer-focused enterprise. His experience and insights will surely benefit Lilly shareholders as we continue to transform our company and deliver on our mission to provide improved outcomes for individual patients."

As president and chief operating officer of McDonald's Corporation since August 2006, Alvarez sets the global strategy and directs operations for the nearly 32,000 McDonald's restaurants in 118 countries. He joined McDonald's Corporation in 1994 and has held a variety of leadership roles throughout his career, including president of McDonald's North America and president and chief operations officer of McDonald's USA. Prior to joining McDonald's in 1994, Alvarez had a lengthy career in the restaurant industry working for Burger King Corporation and Wendy's International, Inc.

Alvarez currently serves on the President's Council and the International Advisory Board of the University of Miami, where he earned his bachelor's degree in Business Administration in 1976. He is also a member of the Board of Directors for McDonald's Corporation and KeyCorp.

An active advocate for Ronald McDonald House Charities, Alvarez is a former president of Ronald McDonald House Charities in Mexico. In addition, he is a member of the Board of Trustees for Chicago's Field Museum.

About Lilly

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

C-LLY

(Logo: http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO )


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Ralphs Pink Tag Campaign to Raise $170,000 for Breast Cancer Awareness in October
2. MUSCs Hollings Cancer Center, Ralph H. Johnson VA Medical Center Partner on New TomoTherapy Treatment for Cancer Patients
3. Ralphs Introduces $4 Generic Drugs
4. Ralphs Expands Discounted Generic Drug Program
5. Ralphs to Invest $240,000 for Breast Cancer Awareness
6. Healthcare Pioneer Dr. Ralph Snyderman to Receive Frost & Sullivans Lifetime Achievement Award
7. Southern California Childrens Hospitals to Receive $125,000 Holiday Gift From Ralphs and Food 4 Less
8. Brooke Franchise Corporation Announces Selected July Results
9. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
10. Draxis Health selected by Johnson and Johnson Consumer Companies, Inc. for major contract manufacturing relationship
11. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... For many women, getting birth control isn’t as easy as it should be. In fact, ... to a health care facility or a pharmacy within 60 minutes of where they live. ... for many who are faced with health or personal issues that leave them homebound. To ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... to be invited to the Siemens Healthineers annual customer education symposium, a world-class ... will take place from March 27 - 31, 2017 at the Atlanta Marriott ...
(Date:3/28/2017)... ... ... Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of the world, is ... about journey and research recently on a blog and discussed some major aspects of ... deal with thyroid disease. , Dr. Wentz completed her graduation from the Midwestern ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... medical society dedicated to advancing the science and clinical practice of radiosurgery, ... RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data collection ...
(Date:3/28/2017)... ... 28, 2017 , ... Z-Medica, LLC, a leading developer and ... (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 ... efforts by the American College of Surgeons, U.S. Department of Defense, Department of ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... CITY, Calif. , March 28, 2017 /PRNewswire/ ... company focused on the development and commercialization of ... pain, announced that the European Medicines Agency (EMA) ... sublingual tablet, 30 mcg) Marketing Authorisation Application (MAA) ... of the MAA is underway. The MAA for ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 The ... reach USD 8.0 billion by 2025, according to a ... incidence of infectious diseases and cancer is expected to ... disease diagnosis over the coming years. In addition, higher ... autologous and allogenic stem cell therapy, due to adverse ...
Breaking Medicine Technology: